Ascendis Pharma A/S Analysis
| Analyst Ratings |
|
Average Target Price
|
0.38
|
|
Average Rating
|
4.57
|
|
# Strong Buys
|
9
|
|
# Buys
|
4
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-2.49
|
-3.03
|
-0.54
|
-21.69%
|
|
2022-06-30
|
-2.13
|
-1.46
|
0.67
|
31.46%
|
|
2022-03-31
|
-2.00
|
-2.21
|
-0.21
|
-10.50%
|
|
2021-12-31
|
-2.34
|
-1.87
|
0.47
|
20.09%
|
|
2021-09-30
|
-2.29
|
-1.47
|
0.82
|
35.81%
|
|
2021-06-30
|
-2.22
|
-2.50
|
-0.28
|
-12.61%
|
|
2021-03-31
|
-1.70
|
-1.17
|
0.53
|
31.18%
|
|
2020-12-31
|
-1.55
|
-2.64
|
-1.09
|
-70.32%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-6.70
|
|
2021-12-31
|
-7.01
|
|
2020-12-31
|
-8.62
|
|
2019-12-31
|
-4.43
|
|
2018-12-31
|
-3.29
|
|
2017-12-31
|
-3.68
|
|
2016-12-31
|
-3.24
|
|
2014-12-31
|
-1.72
|